A citation-based method for searching scientific literature

Jean-Pierre Pignon, Hélène Tribodet, Giorgio V Scagliotti, Jean-Yves Douillard, Frances A Shepherd, Richard J Stephens, Ariane Dunant, Valter Torri, Rafael Rosell, Lesley Seymour, Stephen G Spiro, Estelle Rolland, Roldano Fossati, Delphine Aubert, Keyue Ding, David Waller, Thierry Le Chevalier. J Clin Oncol 2008
Times Cited: 1324







List of co-cited articles
390 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer.
Rodrigo Arriagada, Bengt Bergman, Ariane Dunant, Thierry Le Chevalier, Jean-Pierre Pignon, Johan Vansteenkiste. N Engl J Med 2004
30

Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial.
Jean-Yves Douillard, Rafael Rosell, Mario De Lena, Francesco Carpagnano, Rodryg Ramlau, Jose Luis Gonzáles-Larriba, Tomasz Grodzki, Jose Rodrigues Pereira, Alain Le Groumellec, Vito Lorusso,[...]. Lancet Oncol 2006
29

Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer.
Yi-Long Wu, Masahiro Tsuboi, Jie He, Thomas John, Christian Grohe, Margarita Majem, Jonathan W Goldman, Konstantin Laktionov, Sang-We Kim, Terufumi Kato,[...]. N Engl J Med 2020
155
26

Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study.
Wen-Zhao Zhong, Qun Wang, Wei-Min Mao, Song-Tao Xu, Lin Wu, Yi Shen, Yong-Yu Liu, Chun Chen, Ying Cheng, Lin Xu,[...]. Lancet Oncol 2018
228
21

Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.
Gary M Strauss, James E Herndon, Michael A Maddaus, David W Johnstone, Elizabeth A Johnson, David H Harpole, Heidi H Gillenwater, Dorothy M Watson, David J Sugarbaker, Richard L Schilsky,[...]. J Clin Oncol 2008
623
19

Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer.
Timothy Winton, Robert Livingston, David Johnson, James Rigas, Michael Johnston, Charles Butts, Yvon Cormier, Glenwood Goss, Richard Inculet, Eric Vallieres,[...]. N Engl J Med 2005
19

The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.
Peter Goldstraw, Kari Chansky, John Crowley, Ramon Rami-Porta, Hisao Asamura, Wilfried E E Eberhardt, Andrew G Nicholson, Patti Groome, Alan Mitchell, Vanessa Bolejack. J Thorac Oncol 2016
19

Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial.
Karen Kelly, Nasser K Altorki, Wilfried E E Eberhardt, Mary E R O'Brien, David R Spigel, Lucio Crinò, Chun-Ming Tsai, Joo-Hang Kim, Eun Kyung Cho, Philip C Hoffman,[...]. J Clin Oncol 2015
219
18

Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
17

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.
Patrick M Forde, Jamie E Chaft, Kellie N Smith, Valsamo Anagnostou, Tricia R Cottrell, Matthew D Hellmann, Marianna Zahurak, Stephen C Yang, David R Jones, Stephen Broderick,[...]. N Engl J Med 2018
685
17


Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non-Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update.
Mark G Kris, Laurie E Gaspar, Jamie E Chaft, Erin B Kennedy, Christopher G Azzoli, Peter M Ellis, Steven H Lin, Harvey I Pass, Rahul Seth, Frances A Shepherd,[...]. J Clin Oncol 2017
128
14

Gefitinib versus placebo in completely resected non-small-cell lung cancer: results of the NCIC CTG BR19 study.
Glenwood D Goss, Chris O'Callaghan, Ian Lorimer, Ming-Sound Tsao, Gregory A Masters, James Jett, Martin J Edelman, Rogerio Lilenbaum, Hak Choy, Fadlo Khuri,[...]. J Clin Oncol 2013
210
13

Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC.
Suresh S Ramalingam, Johan Vansteenkiste, David Planchard, Byoung Chul Cho, Jhanelle E Gray, Yuichiro Ohe, Caicun Zhou, Thanyanan Reungwetwattana, Ying Cheng, Busyamas Chewaskulyong,[...]. N Engl J Med 2020
507
13

Erlotinib versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer (EVAN): a randomised, open-label, phase 2 trial.
Dongsheng Yue, Shidong Xu, Qun Wang, Xiaofei Li, Yi Shen, Heng Zhao, Chun Chen, Weimin Mao, Wei Liu, Junfeng Liu,[...]. Lancet Respir Med 2018
95
13

Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data.
R Arriagada, A Auperin, S Burdett, J P Higgins, D H Johnson, T Le Chevalier, C Le Pechoux, M K B Parmar, J P Pignon, R L Souhami,[...]. Lancet 2010
382
12

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
12

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.
Scott J Antonia, Augusto Villegas, Davey Daniel, David Vicente, Shuji Murakami, Rina Hui, Takashi Yokoi, Alberto Chiappori, Ki H Lee, Maike de Wit,[...]. N Engl J Med 2017
11

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
Martin Reck, Delvys Rodríguez-Abreu, Andrew G Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinead Cuffe,[...]. N Engl J Med 2016
10

Adjuvant cisplatin and vinorelbine for completely resected non-small cell lung cancer: subgroup analysis of the Lung Adjuvant Cisplatin Evaluation.
Jean-Yves Douillard, Hélène Tribodet, Delphine Aubert, Frances A Shepherd, Rafael Rosell, Keyue Ding, Anne-Sophie Veillard, Lesley Seymour, Thierry Le Chevalier, Stephen Spiro,[...]. J Thorac Oncol 2010
140
10

Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial.
Heather A Wakelee, Suzanne E Dahlberg, Steven M Keller, William J Tester, David R Gandara, Stephen L Graziano, Alex A Adjei, Natasha B Leighl, Seena C Aisner, Jan M Rothman,[...]. Lancet Oncol 2017
74
13

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.
Scott J Antonia, Augusto Villegas, Davey Daniel, David Vicente, Shuji Murakami, Rina Hui, Takayasu Kurata, Alberto Chiappori, Ki H Lee, Maike de Wit,[...]. N Engl J Med 2018
10

Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.
Jean-Charles Soria, Yuichiro Ohe, Johan Vansteenkiste, Thanyanan Reungwetwattana, Busyamas Chewaskulyong, Ki Hyeong Lee, Arunee Dechaphunkul, Fumio Imamura, Naoyuki Nogami, Takayasu Kurata,[...]. N Engl J Med 2018
10

Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10.
Charles A Butts, Keyue Ding, Lesley Seymour, Philip Twumasi-Ankrah, Barbara Graham, David Gandara, David H Johnson, Kenneth A Kesler, Mark Green, Mark Vincent,[...]. J Clin Oncol 2010
246
9

Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial.
Catherine A Shu, Justin F Gainor, Mark M Awad, Codruta Chiuzan, Claud M Grigg, Aliyah Pabani, Robert F Garofano, Mark B Stoopler, Simon K Cheng, Abby White,[...]. Lancet Oncol 2020
100
9

Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
P E Postmus, K M Kerr, M Oudkerk, S Senan, D A Waller, J Vansteenkiste, C Escriu, S Peters. Ann Oncol 2017
604
9


Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer.
Giorgio V Scagliotti, Roldano Fossati, Valter Torri, Lucio Crinò, Giuseppe Giaccone, Giovanni Silvano, Massimo Martelli, Maurizia Clerici, Francesco Cognetti, Maurizio Tonato. J Natl Cancer Inst 2003
423
8

SELECT: A Phase II Trial of Adjuvant Erlotinib in Patients With Resected Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer.
Nathan A Pennell, Joel W Neal, Jamie E Chaft, Christopher G Azzoli, Pasi A Jänne, Ramaswamy Govindan, Tracey L Evans, Daniel B Costa, Heather A Wakelee, Rebecca S Heist,[...]. J Clin Oncol 2019
73
10


Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.
Leena Gandhi, Delvys Rodríguez-Abreu, Shirish Gadgeel, Emilio Esteban, Enriqueta Felip, Flávia De Angelis, Manuel Domine, Philip Clingan, Maximilian J Hochmair, Steven F Powell,[...]. N Engl J Med 2018
7

Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.
Christopher Abbosh, Nicolai J Birkbak, Gareth A Wilson, Mariam Jamal-Hanjani, Tudor Constantin, Raheleh Salari, John Le Quesne, David A Moore, Selvaraju Veeriah, Rachel Rosenthal,[...]. Nature 2017
641
7

Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non-small cell lung cancer.
Matthew J Bott, Stephen C Yang, Bernard J Park, Prasad S Adusumilli, Valerie W Rusch, James M Isbell, Robert J Downey, Julie R Brahmer, Richard Battafarano, Errol Bush,[...]. J Thorac Cardiovasc Surg 2019
86
8

Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC.
Shugeng Gao, Ning Li, Shunyu Gao, Qi Xue, Jianming Ying, Shuhang Wang, Xiuli Tao, Jun Zhao, Yousheng Mao, Bing Wang,[...]. J Thorac Oncol 2020
69
10

Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling.
Aadel A Chaudhuri, Jacob J Chabon, Alexander F Lovejoy, Aaron M Newman, Henning Stehr, Tej D Azad, Michael S Khodadoust, Mohammad Shahrokh Esfahani, Chih Long Liu, Li Zhou,[...]. Cancer Discov 2017
287
7

Sequencing of Postoperative Radiotherapy and Chemotherapy for Locally Advanced or Incompletely Resected Non-Small-Cell Lung Cancer.
Samual Francis, Andrew Orton, Greg Stoddard, Randa Tao, Ying J Hitchcock, Wallace Akerley, Kristine E Kokeny. J Clin Oncol 2018
28
21

Postoperative radiotherapy is associated with better survival in non-small cell lung cancer with involved N2 lymph nodes: results of an analysis of the National Cancer Data Base.
John L Mikell, Theresa W Gillespie, William A Hall, Dana C Nickleach, Yuan Liu, Joseph Lipscomb, Suresh S Ramalingam, Raj S Rajpara, Seth D Force, Felix G Fernandez,[...]. J Thorac Oncol 2015
62
9

Postoperative radiotherapy for pathologic N2 non-small-cell lung cancer treated with adjuvant chemotherapy: a review of the National Cancer Data Base.
Cliff G Robinson, Aalok P Patel, Jeffrey D Bradley, Todd DeWees, Saiama N Waqar, Daniel Morgensztern, Maria Q Baggstrom, Ramaswamy Govindan, Jennifer M Bell, Tracey J Guthrie,[...]. J Clin Oncol 2015
133
6

Adjuvant Chemotherapy for Patients with T2N0M0 NSCLC.
Daniel Morgensztern, Lingling Du, Saiama N Waqar, Aalok Patel, Pamela Samson, Siddhartha Devarakonda, Feng Gao, Cliff G Robinson, Jeffrey Bradley, Maria Baggstrom,[...]. J Thorac Oncol 2016
41
14

Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
Jan P van Meerbeeck, Gijs W P M Kramer, Paul E Y Van Schil, Catherine Legrand, Egbert F Smit, Franz Schramel, Vivianne C Tjan-Heijnen, Bonne Biesma, Channa Debruyne, Nico van Zandwijk,[...]. J Natl Cancer Inst 2007
441
6

Early stage NSCLC - challenges to implementing ctDNA-based screening and MRD detection.
Christopher Abbosh, Nicolai J Birkbak, Charles Swanton. Nat Rev Clin Oncol 2018
113
6

Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease.
Jing Liu, Stephen J Blake, Michelle C R Yong, Heidi Harjunpää, Shin Foong Ngiow, Kazuyoshi Takeda, Arabella Young, Jake S O'Donnell, Stacey Allen, Mark J Smyth,[...]. Cancer Discov 2016
286
6

Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer.
Matthew D Hellmann, Luis Paz-Ares, Reyes Bernabe Caro, Bogdan Zurawski, Sang-We Kim, Enric Carcereny Costa, Keunchil Park, Aurelia Alexandru, Lorena Lupinacci, Emmanuel de la Mora Jimenez,[...]. N Engl J Med 2019
666
6

Adjuvant chemotherapy for resected early-stage non-small cell lung cancer.
Sarah Burdett, Jean Pierre Pignon, Jayne Tierney, Helene Tribodet, Lesley Stewart, Cecile Le Pechoux, Anne Aupérin, Thierry Le Chevalier, Richard J Stephens, Rodrigo Arriagada,[...]. Cochrane Database Syst Rev 2015
113
6

The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer.
Hisao Asamura, Kari Chansky, John Crowley, Peter Goldstraw, Valerie W Rusch, Johan F Vansteenkiste, Hirokazu Watanabe, Yi-Long Wu, Marcin Zielinski, David Ball,[...]. J Thorac Oncol 2015
302
5

The biology and management of non-small cell lung cancer.
Roy S Herbst, Daniel Morgensztern, Chris Boshoff. Nature 2018
5

Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database.
Brian E Lally, Daniel Zelterman, Joseph M Colasanto, Bruce G Haffty, Frank C Detterbeck, Lynn D Wilson. J Clin Oncol 2006
298
5


Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer.
Luis Paz-Ares, Alexander Luft, David Vicente, Ali Tafreshi, Mahmut Gümüş, Julien Mazières, Barbara Hermes, Filiz Çay Şenler, Tibor Csőszi, Andrea Fülöp,[...]. N Engl J Med 2018
5

Cancer statistics, 2019.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2019
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.